By
Drug Target Review2024-04-04T15:00:03
The compound 11c demonstrates an excellent safety profile and is an exciting advancement in liver disease management.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-15T09:36:00Z
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-26T13:22:42
Sponsored by bit.bio
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud